These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38432284)

  • 1. Out-of-Pocket Cost Modeling of Adjuvant Antiestrogen and Radiation Therapy After Lumpectomy for Early-Stage Breast Cancer Across Medicaid and Medicare Plans.
    Wu VS; Khlopin M; Chadha M; Smith-Graziani DJ; Jagsi R; McClelland S
    Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1379-1385. PubMed ID: 38432284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out-of-Pocket Cost Modeling of Adjuvant Radiation Therapy Duration in Standard-of-Care Early Stage Breast Cancer Treatment Across Medicaid and Medicare Plans.
    Wu VS; Khlopin M; Jagsi R; McClelland S
    Pract Radiat Oncol; 2024; 14(1):24-27. PubMed ID: 37748680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017.
    Bartlett VL; Liu P; Dhruva SS; Shah ND; Bollinger KE; Ross JS
    J Manag Care Spec Pharm; 2020 Apr; 26(4):562-567. PubMed ID: 32223594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissemination of clinical results. Mastectomy versus lumpectomy and radiation therapy.
    Young WW; Marks SM; Kohler SA; Hsu AY
    Med Care; 1996 Oct; 34(10):1003-17. PubMed ID: 8843927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.
    Barlow WE; Taplin SH; Yoshida CK; Buist DS; Seger D; Brown M
    J Natl Cancer Inst; 2001 Mar; 93(6):447-55. PubMed ID: 11259470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
    Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
    PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.
    Sloan CE; Millo L; Gutterman S; Ubel PA
    JAMA Netw Open; 2021 Nov; 4(11):e2133188. PubMed ID: 34739059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
    Yazdany J; Dudley RA; Chen R; Lin GA; Tseng CW
    Arthritis Rheumatol; 2015 Jun; 67(6):1474-80. PubMed ID: 25900105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
    Narang AK; Nicholas LH
    JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.
    Roberts KB; Soulos PR; Herrin J; Yu JB; Long JB; Dostaler E; Gross CP
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1186-92. PubMed ID: 23182396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-Pocket Costs for Prostate Cancer Medications Substantially Vary by Medicare Part D Plan: An Online Tool Presents an Opportunity to Mitigate Financial Toxicity.
    Pockros B; Shabet C; Stensland K; Herrel L
    Urol Pract; 2023 Sep; 10(5):467-475. PubMed ID: 37347766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.
    Shirvani SM; Jiang J; Likhacheva A; Hoffman KE; Shaitelman SF; Caudle A; Buchholz TA; Giordano SH; Smith BD
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):605-16. PubMed ID: 27034179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receipt of chemotherapy among medicare patients with cancer by type of supplemental insurance.
    Warren JL; Butler EN; Stevens J; Lathan CS; Noone AM; Ward KC; Harlan LC
    J Clin Oncol; 2015 Feb; 33(4):312-8. PubMed ID: 25534387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
    Suidan RS; He W; Sun CC; Zhao H; Rauh-Hain JA; Fleming ND; Lu KH; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Aug; 221(2):136.e1-136.e9. PubMed ID: 30965052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women.
    Sabatino SA; Thompson TD; Miller JW; Breen N; White MC; Breslau E; Shoemaker ML
    J Womens Health (Larchmt); 2019 Jul; 28(7):910-918. PubMed ID: 30265611
    [No Abstract]   [Full Text] [Related]  

  • 18. The Association Between Type of Insurance Plan, Out-of-Pocket Cost, and Adherence to Antihypertensive Medications in Medicare Supplement Insurance Enrollees.
    Zhang D; Xu J; Hall DB; Chen X; Chen M; Divers J; Wei J; Rajbhandari-Thapa J; Wright DR; Arabadjian M; Young HN
    Am J Hypertens; 2024 Jul; 37(8):631-639. PubMed ID: 38727326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of Patient Out-of-Pocket Cost for Radiation Therapy by Insurance Type and Treatment Modality.
    Chen LW; Cao Y; D'Rummo K; Shen X
    Pract Radiat Oncol; 2022; 12(6):e481-e485. PubMed ID: 35447387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.